Scarica l'app Stockscreener
2.31
4.55%
-0.11
Dopo l'orario di chiusura:
2.31
Precedente Chiudi:
$2.42
Aprire:
$2.4
Volume 24 ore:
17,848
Relative Volume:
0.16
Capitalizzazione di mercato:
$29.37M
Reddito:
$10.96M
Utile/perdita netta:
$-7.02M
Rapporto P/E:
-3.6094
EPS:
-0.64
Flusso di cassa netto:
$-3.72M
1 W Prestazione:
+13.79%
1M Prestazione:
+58.76%
6M Prestazione:
-37.74%
1 anno Prestazione:
-50.64%
Intervallo 1D:
$2.2447
$2.40
Intervallo di 1 settimana:
$2.03
$2.46
Portata 52W:
$1.31
$5.45
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Nome
Collplant Biotechnologies Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta CLGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
2.31 | 30.77M | 10.96M | -7.02M | -3.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-02-17 | Iniziato | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Borsa (CLGN) Ultime notizie
What institutional investors are buying CollPlant Biotechnologies Ltd. stockInvest smarter with high-probability setups - jammulinksnews.com
What are analysts’ price targets for CollPlant Biotechnologies Ltd. in the next 12 monthsTriple-digit returns - jammulinksnews.com
What are the technical indicators suggesting about CollPlant Biotechnologies Ltd.Free Wealth Management Insights - jammulinksnews.com
Why CollPlant Biotechnologies Ltd. stock attracts strong analyst attentionFree Stock Market Real-Time Monitoring - Newser
How Interest Rate Changes Impact CollPlant Biotechnologies Ltd. Stock PerformanceFree Best Performing Stock Alerts - Newser
CollPlant Biotechnologies Ltd. Stock Analysis and ForecastBreakthrough investment results - PrintWeekIndia
What drives CollPlant Biotechnologies Ltd. stock priceTriple-digit return opportunities - PrintWeekIndia
Is CollPlant Biotechnologies Ltd. a good long term investmentDynamic investment growth - Autocar Professional
What analysts say about CollPlant Biotechnologies Ltd. stockDynamic portfolio growth - Autocar Professional
What makes CollPlant Biotechnologies Ltd. stock price move sharplyLow Risk Profit Ideas - Newser
How CollPlant Biotechnologies Ltd. stock performs during market volatilityFree Predictions - Newser
Brown Advisory Inc. Sells 8,265 Shares of CollPlant Biotechnologies Ltd. Sponsored ADR (NASDAQ:CLGN) - Defense World
Tissue Engineering Market Attracts Investment in Stem Cell - openPR.com
CollPlant names new VP to lead North American commercial operations - Investing.com Australia
COLLPLANT BIOTECHNOLOGIESNEW Earnings Preview: Recent $CLGN Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Collplant Biotechnologies Ltd expected to post a loss of 14 cents a shareEarnings Preview - TradingView
CLGN 6-K: CollPlant Announces New North America Commercial Head | MS SEC FilingForm 424B2 - Stock Titan
CLGN 6-K: CollPlant Announces New North America Commercial Head | CLGN SEC FilingForm 6-K - Stock Titan
CollPlant names new VP to lead North American commercial operations By Investing.com - Investing.com South Africa
CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations - Financial Times
CollPlant Biotechnologies (NASDAQ:CLGN) Trading Up 2.1% – Should You Buy? - Defense World
Collplant Biotechnologies Ltd Azioni (CLGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):